Search results
Showing 7456 to 7470 of 8314 results
Common mental health problems: identification and pathways to care (CG123)
We withdrew this guideline in May 2024, because all of the recommendations are now covered in other NICE guidelines, or are out of date and no longer relevant to clinical practice. For guidance on common mental health problems, see our guidelines on: Depression in adults Depression in adults with a chronic physical health problem Depression in children and young people Generalised anxiety disorder and panic disorder in adults Obsessive-compulsive disorder and body dysmorphic disorder Social anxiety disorder
COVID-19 rapid guideline: arranging planned care in hospitals and diagnostic services (NG179)
May 2022: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. For people with COVID-19 see our guideline on managing COVID-19.
This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. For people with COVID-19 see our guideline on managing COVID-19.
This guidance has been updated and replaced by NICE guideline NG81.
Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia (DG2)
Both index tests included in this guidance are no longer commercially available. Therefore the guidance has been withdrawn.
July 2022: The guidance has been withdrawn because PCR tests now form part of standard care. Since the diagnostics guidance was published, expert advice suggests that clinical practice has moved on; PCR testing using a centralised approach is widely available in the NHS and adoption is growing. The UK standards for Microbiology Investigation also provide additional support for the PCR-based diagnostic tests.
Irreversible electroporation for treating pancreatic cancer (IPG442)
Interventional procedures, IPG442 - Issued: February 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 579.
Interventional procedures, IPG463 - Issued: August 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 711.
Interventional procedures, IPG454 - Issued: April 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 603.
Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma (IPG447)
Interventional procedures, IPG447 - Issued: March 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 478.
Sutureless aortic valve replacement for aortic stenosis (IPG456)
Interventional procedures, IPG456 - Issued: July 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 624.
Interventional procedures, IPG479 - Issued: February 2014 --> This guidance has been updated and replaced by NICE interventional procedures guidance 631.
Insertion of endobronchial valves for lung volume reduction in emphysema (IPG465)
Interventional procedures, IPG465 - Issued: September 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 600.
Interventional procedures, IPG51 - Issued: March 2004 --> This guidance has been withdrawn as the use of this procedure is now covered in the NICE guideline on heavy menstrual bleeding: assessment and management. NICE has no plans to carry out further assessment of this procedure under the Interventional Procedures Programme.
Transcatheter valve-in-valve implantation for aortic bioprosthetic valve dysfunction (IPG504)
Interventional procedures, IPG504 - Issued: September 2014 --> This guidance has been updated and replaced by NICE interventional procedures guidance 653.